3,4-difluoro-2-((2-fluoro-4-iodophenyl)(methyl)amino)benzoicacid

ID: ALA4127455

PubChem CID: 117956192

Max Phase: Preclinical

Molecular Formula: C14H9F3INO2

Molecular Weight: 407.13

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(c1ccc(I)cc1F)c1c(C(=O)O)ccc(F)c1F

Standard InChI:  InChI=1S/C14H9F3INO2/c1-19(11-5-2-7(18)6-10(11)16)13-8(14(20)21)3-4-9(15)12(13)17/h2-6H,1H3,(H,20,21)

Standard InChI Key:  YRAJKOMCYWWATE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   10.3939   -8.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3939   -9.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1083   -9.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1083  -10.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3939  -10.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6794  -10.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6794   -9.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6794   -7.9000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1083   -7.9000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8228   -9.1375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8228   -8.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5373   -9.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2518   -9.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9662   -9.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9662  -10.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2518  -10.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5373  -10.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6807  -10.7875    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   13.2518   -8.3125    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.3939  -11.6125    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.8228  -10.7875    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  1  8  2  0
  1  9  1  0
 10 11  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 15 18  1  0
 13 19  1  0
 10 12  1  0
  3 10  1  0
  5 20  1  0
  4 21  1  0
M  END

Associated Targets(Human)

MAP2K2 Tclin Dual specificity mitogen-activated protein kinase kinase; MEK1/2 (426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K5 Tchem Dual specificity mitogen-activated protein kinase kinase 5 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.13Molecular Weight (Monoisotopic): 406.9630AlogP: 4.17#Rotatable Bonds: 3
Polar Surface Area: 40.54Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.48CX Basic pKa: CX LogP: 4.65CX LogD: 1.27
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.78Np Likeness Score: -1.42

References

1. Chakrabarty S, Monlish DA, Gupta M, Wright TD, Hoang VT, Fedak M, Chopra I, Flaherty PT, Madura J, Mannepelli S, Burow ME, Cavanaugh JE..  (2018)  Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways.,  28  (13): [PMID:29803729] [10.1016/j.bmcl.2018.05.029]

Source